• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度行为障碍:阿尔茨海默病痴呆的早期迹象和预测指标。

Mild Behavioral Impairment: An Early Sign and Predictor of Alzheimer's Disease Dementia.

机构信息

Clinical Research Center for Psychiatry, Dalian Seventh Peolpe\'s Hospital, Dalian 116023, China.

Liaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian 116021, China.

出版信息

Curr Alzheimer Res. 2022;19(6):407-419. doi: 10.2174/1567205019666220805114528.

DOI:10.2174/1567205019666220805114528
PMID:35929623
Abstract

BACKGROUND

Alzheimer's disease (AD) is the most common form of dementia in the elderly population and places heavy burdens on medical care and nursing. Recently, the psychiatric and behavioral symptoms of prodromal AD, especially mild behavioral impairment (MBI), have attracted much attention. In 2012, Alzheimer's Association International Conference, MBI was proposed as a syndrome with psychiatric and behavioral disturbance before the onset of typical clinical cognitive symptoms in dementia. Increasing lines of evidence have indicated the link between MBI and early AD pathologies including Aβ and tau.

OBJECTIVE

This narrative review aims to summarize the advantages of MBI over other concept of psychiatric and behavioral symptoms associated with AD in the early prediction of AD dementia. We also discuss the possible common genetic basis and pathological mechanisms underlying the interactions between MBI and AD.

METHODS

Papers cited here were retrieved from PubMed up to February 2022. We selected a total of 95 articles for summary and discussion.

RESULTS

The occurrence of MBI is mainly due to the overlapped genetic and pathological risk factors with AD and is related to the brain's response to environmental stressors. MBI may be a warning sign for the early pathology of AD, and more attention should be paid on the number and duration of MBI symptoms.

CONCLUSION

MBI may be an early sign and predictor of Alzheimer's disease dementia. Early intervention for MBI may have a positive effect on alleviating long-term cognitive decline.

摘要

背景

阿尔茨海默病(AD)是老年人群中最常见的痴呆症形式,给医疗和护理带来了沉重的负担。最近,前驱 AD 的精神和行为症状,尤其是轻度行为障碍(MBI),引起了广泛关注。2012 年,阿尔茨海默病协会国际会议提出,MBI 是痴呆症患者典型临床认知症状出现之前出现的精神和行为障碍综合征。越来越多的证据表明,MBI 与 AD 早期病理之间存在联系,包括 Aβ 和 tau。

目的

本综述旨在总结 MBI 在 AD 早期预测中的优势,相较于 AD 相关的其他精神和行为症状概念。我们还讨论了 MBI 和 AD 之间相互作用的可能共同遗传基础和病理机制。

方法

本文引用的文献均来自 PubMed,检索时间截至 2022 年 2 月。我们共选择了 95 篇文章进行总结和讨论。

结果

MBI 的发生主要归因于与 AD 重叠的遗传和病理风险因素,以及与大脑对环境应激源的反应有关。MBI 可能是 AD 早期病理的一个警告信号,应该更加关注 MBI 症状的数量和持续时间。

结论

MBI 可能是阿尔茨海默病痴呆的早期征象和预测指标。对 MBI 进行早期干预可能对缓解长期认知衰退有积极作用。

相似文献

1
Mild Behavioral Impairment: An Early Sign and Predictor of Alzheimer's Disease Dementia.轻度行为障碍:阿尔茨海默病痴呆的早期迹象和预测指标。
Curr Alzheimer Res. 2022;19(6):407-419. doi: 10.2174/1567205019666220805114528.
2
CTAD Task Force Paper: Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force.CTAD 工作组文件:AD 中的神经精神症状:针对轻度行为障碍的临床试验:国际 CTAD 工作组的报告。
J Prev Alzheimers Dis. 2024;11(1):56-64. doi: 10.14283/jpad.2023.125.
3
Prevalence of Mild Behavioral Impairment and Risk of Dementia in a Psychiatric Outpatient Clinic.精神科门诊轻度行为障碍的患病率及其痴呆风险。
J Alzheimers Dis. 2019;70(2):505-513. doi: 10.3233/JAD-190278.
4
Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.中文版轻度行为障碍检查表在轻度认知障碍和轻度阿尔茨海默病中的信度和效度。
J Alzheimers Dis. 2021;81(3):1141-1149. doi: 10.3233/JAD-210098.
5
Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer's Disease.《轻度行为障碍清单中文版筛查阿尔茨海默病的信度和效度》。
J Alzheimers Dis. 2019;70(3):747-756. doi: 10.3233/JAD-190113.
6
Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.轻度行为障碍与阿尔茨海默病的进展相关:一项临床病理研究。
Alzheimers Dement. 2022 Nov;18(11):2199-2208. doi: 10.1002/alz.12519. Epub 2022 Feb 1.
7
Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer's Disease.探索轻度行为障碍的遗传特征作为认知能力下降的早期标志物:关注阿尔茨海默病的最新综述。
Int J Mol Sci. 2024 Feb 24;25(5):2645. doi: 10.3390/ijms25052645.
8
Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's disease.轻度行为障碍:临床前阿尔茨海默病新型标志物的测量及临床相关性。
Alzheimers Res Ther. 2022 Jan 5;14(1):2. doi: 10.1186/s13195-021-00949-7.
9
Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.轻度认知障碍和主观认知下降患者轻度行为损害的患病率及其与照料者负担的关系。
Int Psychogeriatr. 2018 Feb;30(2):233-244. doi: 10.1017/S104161021700151X. Epub 2017 Sep 7.
10
Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment.血浆神经丝轻链:轻度行为障碍中神经退行性变的标志物。
J Alzheimers Dis. 2020;76(3):1017-1027. doi: 10.3233/JAD-200011.

引用本文的文献

1
Risk factors of mild behavioral impairment: a systematic review.轻度行为障碍的风险因素:一项系统综述。
Front Psychol. 2025 Jun 27;16:1586418. doi: 10.3389/fpsyg.2025.1586418. eCollection 2025.
2
Multivariate longitudinal clustering reveals neuropsychological factors as dementia predictors in an Alzheimer's disease progression study.多变量纵向聚类分析揭示了在一项阿尔茨海默病进展研究中,神经心理学因素可作为痴呆症的预测指标。
BioData Min. 2025 Mar 28;18(1):26. doi: 10.1186/s13040-025-00441-0.
3
Menopausal symptom burden as a predictor of mid- to late-life cognitive function and mild behavioral impairment symptoms: A CAN-PROTECT study.
更年期症状负担作为中老年认知功能和轻度行为障碍症状的预测指标:一项CAN - PROTECT研究。
PLoS One. 2025 Mar 5;20(3):e0301165. doi: 10.1371/journal.pone.0301165. eCollection 2025.
4
Evaluating p-tau217 and p-tau231 as Biomarkers for Early Diagnosis and Differentiation of Alzheimer's Disease: A Narrative Review.评估p- tau217和p- tau231作为阿尔茨海默病早期诊断和鉴别的生物标志物:一项叙述性综述
Biomedicines. 2024 Apr 3;12(4):786. doi: 10.3390/biomedicines12040786.
5
Applying the Consensus Criteria for Traumatic Encephalopathy Syndrome Retrospectively to Case Studies of Boxers from the 20th Century.将创伤性脑病综合征的共识标准回顾性应用于20世纪拳击手的案例研究。
Neurotrauma Rep. 2024 Apr 3;5(1):337-347. doi: 10.1089/neur.2023.0134. eCollection 2024.
6
Neuropsychiatric Symptoms Predict Faster Cognitive Decline in Dementia Collaborative Care Than Antipsychotic Use.与使用抗精神病药物相比,神经精神症状预示着痴呆症协作护理中认知功能衰退更快。
Neuropsychiatr Dis Treat. 2024 Mar 26;20:689-696. doi: 10.2147/NDT.S454943. eCollection 2024.
7
Prodromal multiple sclerosis: considerations and future utility.前驱期多发性硬化症:考虑因素和未来应用。
J Neurol. 2024 Apr;271(4):2129-2140. doi: 10.1007/s00415-023-12173-4. Epub 2024 Feb 11.
8
Using digital assessment technology to detect neuropsychological problems in primary care settings.在初级保健环境中使用数字评估技术来检测神经心理问题。
Front Psychol. 2023 Nov 17;14:1280593. doi: 10.3389/fpsyg.2023.1280593. eCollection 2023.
9
The Global Deterioration Scale for Down Syndrome Population (GDS-DS): A Rating Scale to Assess the Progression of Alzheimer's Disease.唐氏综合征人群全球衰退量表(GDS-DS):一种评估阿尔茨海默病进展的评定量表。
Int J Environ Res Public Health. 2023 Mar 14;20(6):5096. doi: 10.3390/ijerph20065096.